Skip to main content
. 2022 Mar 11;22:62. doi: 10.1186/s12902-022-00982-z

Table 3.

Multivariate logistic regression analyses of serum EV ARG 1 levels and different duration of T2DM

EV ARG 1 (per 10 pg/mL increase) No. of patients Unadjusted Model 1 Model 2 Model 3
OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value
Total 103 1.318 (1.165–1.492) < 0.001 1.376 (1.194–1.585) < 0.001 1.450 (1.135–1.851) 0.003 1.388 (1.155–1.669) < 0.001
Non-T2DM (Reference) 18 1.000 1.000 1.000 1.000
Prediabetes 12 0.857 (0.711–1.034) 0.107 0.880 (0.729–1.063) 0.184 0.889 (0.694–1.139) 0.239 0.897 (0.696–1.157) 0.831
< 4, years 24 1.177 (1.007–1.374) 0.040 1.220 (1.025–1.453) 0.025 1.230 (1.014–1.492) 0.036 1.194 (1.001–1.424) 0.048
4–10, years 26 1.213 (1.051–1.400) 0.008 1.417 (1.065–1.886) 0.017 1.400 (1.071–1.829) 0.014 1.425 (1.098–1.850) 0.008
> 10, years 23 1.386 (1.101–1.743) 0.005 1.488 (1.109–1.997) 0.008 1.734 (1.040–2.890) 0.035 1.651 (1.066–2.557) 0.025

EV Extracellular vesicles, T2DM Type 2 diabetes mellitus, ARG 1 Arginase 1, SBP Systolic blood pressure, BMI Body Mass Index, TG Triglyceride, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, hs-CRP High-sensitivity C-reactive protein, OR Odds Ratio, CI Confidence Interval

Model 1: adjusted for age, sex, and BMI;

Model 2: adjusted for Model 1 + smoke, drink, SBP, TC, TG, hs-CRP

Model 3: adjusted for Model 2 + coronary heart disease

*p < 0.05, **p < 0.001